Analysts Set Avantor, Inc. (NYSE:AVTR) PT at $13.97

Avantor, Inc. (NYSE:AVTR) has been assigned an average recommendation of “Hold” from the seventeen brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $13.60.

AVTR has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. restated a “neutral” rating and set a $12.00 target price (down previously from $14.00) on shares of Avantor in a report on Thursday, October 30th. UBS Group set a $12.00 target price on shares of Avantor in a report on Thursday, October 30th. TD Cowen lowered their price target on Avantor from $14.00 to $12.00 and set a “hold” rating on the stock in a report on Wednesday. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Monday, December 29th. Finally, Raymond James Financial downgraded Avantor from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 4th.

Insiders Place Their Bets

In related news, Director Sanjeev K. Mehra purchased 350,000 shares of the company’s stock in a transaction that occurred on Friday, December 5th. The stock was bought at an average price of $11.09 per share, for a total transaction of $3,881,500.00. Following the completion of the transaction, the director owned 350,000 shares in the company, valued at approximately $3,881,500. The trade was a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Gregory L. Summe acquired 100,000 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the acquisition, the director owned 300,000 shares in the company, valued at $3,375,000. This trade represents a 50.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 1.20% of the company’s stock.

Institutional Investors Weigh In On Avantor

A number of institutional investors and hedge funds have recently bought and sold shares of AVTR. Northwestern Mutual Wealth Management Co. raised its stake in Avantor by 288.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock worth $28,000 after buying an additional 1,263 shares in the last quarter. Vident Advisory LLC purchased a new stake in Avantor in the first quarter valued at about $419,000. Royal Bank of Canada increased its holdings in shares of Avantor by 104.3% during the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after acquiring an additional 104,022 shares in the last quarter. Federation des caisses Desjardins du Quebec raised its holdings in shares of Avantor by 37.5% in the first quarter. Federation des caisses Desjardins du Quebec now owns 120,169 shares of the company’s stock worth $1,948,000 after buying an additional 32,777 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new position in shares of Avantor in the 1st quarter valued at $4,863,000. 95.08% of the stock is owned by institutional investors.

Avantor Trading Down 1.5%

Shares of AVTR opened at $12.09 on Monday. Avantor has a 1-year low of $10.62 and a 1-year high of $23.32. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.49 and a quick ratio of 0.96. The firm’s 50 day simple moving average is $11.41 and its 200 day simple moving average is $12.61. The company has a market capitalization of $8.24 billion, a P/E ratio of -92.96, a P/E/G ratio of 4.25 and a beta of 0.93.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The business had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.Avantor’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.26 EPS. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Sell-side analysts forecast that Avantor will post 1.06 earnings per share for the current fiscal year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.